{"id":"W4388047647","doi":"10.1007/s00415-023-11943-4","title":"Ocrelizumab exposure in relapsing–remitting multiple sclerosis: 10-year analysis of the phase 2 randomized clinical trial and its extension","year":2023,"lang":"en","type":"article","venue":"Journal of Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia","funders":"University College London Hospitals NHS Foundation Trust; National Institute for Health and Care Research; Universität Basel; F. Hoffmann-La Roche","keywords":"Ocrelizumab; Medicine; Multiple sclerosis; Placebo; Adverse effect; Internal medicine; Neurology; Randomized controlled trial; Immunology; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.006864566,0.0001414892,0.001752385,0.0008161765,0.00008062623,0.00001007039,0.000175276,0.0001743014,0.00004749876],"category_scores_gemma":[0.04319733,0.00008426922,0.0007467202,0.001253939,0.0002931459,0.00006630904,0.0002106513,0.0008509633,0.000003149386],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001716584,"about_ca_system_score_gemma":0.0001022335,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001002202,"about_ca_topic_score_gemma":0.0000172177,"domain_scores_codex":[0.9950181,0.002136356,0.001740235,0.0002618973,0.0005524967,0.0002909398],"domain_scores_gemma":[0.9920862,0.006178311,0.0009128642,0.0002697123,0.0004200508,0.0001328146],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.925081,0.0006573927,0.04505694,0.00003972983,0.001498631,0.0001325899,0.0003757805,0.0003089714,0.0203035,0.000005557801,0.00137311,0.005166839],"study_design_scores_gemma":[0.6365311,0.00251028,0.338505,0.0001405211,0.001010656,0.00002993054,0.00009146825,0.02076912,0.0001904557,0.00001082478,0.0001517727,0.00005884666],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9940972,0.0007444805,0.000008711387,0.004014615,0.0004819147,0.0006050372,0.00000540233,0.00001114544,0.00003146421],"genre_scores_gemma":[0.9944525,0.004918369,0.00007007063,0.0002340279,0.0002531881,0.000009332036,0.000001830251,0.00001551861,0.00004514306],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2934481,"threshold_uncertainty_score":0.9648622,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1691772000045825,"score_gpt":0.4105459403302391,"score_spread":0.2413687403256565,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}